These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3133339)
1. Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice. Inaba M; Kobayashi T; Tashiro T; Sakurai Y Jpn J Cancer Res; 1988 Apr; 79(4):509-16. PubMed ID: 3133339 [TBL] [Abstract][Full Text] [Related]
2. Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents. Inaba M; Tashiro T; Kobayashi T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T Jpn J Cancer Res; 1988 Apr; 79(4):517-22. PubMed ID: 3133340 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose. Inaba M; Kobayashi T; Tashiro T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T Cancer; 1989 Oct; 64(8):1577-82. PubMed ID: 2507122 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents]. Inaba M Gan To Kagaku Ryoho; 1991 Jul; 18(9):1449-56. PubMed ID: 1906701 [TBL] [Abstract][Full Text] [Related]
5. A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors. Imaizumi M; Kondo T; Taguchi T; Hattori T; Abe O; Kitano M; Wakui A Surg Today; 1993; 23(5):412-9. PubMed ID: 8324334 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse. Inaba M; Tashiro T; Kobayashi T; Fujimoto S; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T Jpn J Cancer Res; 1986 Feb; 77(2):190-6. PubMed ID: 3082831 [TBL] [Abstract][Full Text] [Related]
7. Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses. Tashiro T; Inaba M; Kobayashi T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T Cancer Chemother Pharmacol; 1989; 24(3):187-92. PubMed ID: 2544308 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study on the evaluation of antineoplastic effects in the human cancer/nude mouse system]. Tashiro T; Fujimoto S; Kobayashi T; Inaba M Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):973-80. PubMed ID: 6408993 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites. Fujimoto S; Ogawa M; Hoshino A Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness of subcutaneous human glioma xenografts to various antitumor agents. Maruo K; Ueyama Y; Inaba M; Emura R; Ohnishi Y; Nakamura O; Sato O; Nomura T Anticancer Res; 1990; 10(1):209-12. PubMed ID: 2334129 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice. Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700 [TBL] [Abstract][Full Text] [Related]
12. Similarity of serum-tumor pharmacokinetics of antitumor agents in man and nude mice. Kubota T; Inoue S; Furukawa T; Ishibiki K; Kitajima M; Kawamura E; Hoffman RM Anticancer Res; 1993; 13(5A):1481-4. PubMed ID: 8239525 [TBL] [Abstract][Full Text] [Related]
13. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity. Fujimoto S; Ogawa M Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931 [TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice. Inoue K; Fujimoto S; Ogawa M Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717 [TBL] [Abstract][Full Text] [Related]
15. Potentiation by vitamin A of the action of anticancer agents against murine tumors. Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose. Fujimoto S; Wang Y; Ogawa M Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235 [TBL] [Abstract][Full Text] [Related]
17. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755 [TBL] [Abstract][Full Text] [Related]
18. Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice. Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Endoh F; Ohta M; Togawa Y; Okui K Jpn J Surg; 1986 Mar; 16(2):133-9. PubMed ID: 2941608 [TBL] [Abstract][Full Text] [Related]
19. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration. Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003 [TBL] [Abstract][Full Text] [Related]
20. [A model for the sensitivity determination of anticancer agents against human cancer using nude mice]. Kondo T; Imaizumi M; Taguchi T; Abe O; Hattori T; Wakui A; Kitano M Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):680-6. PubMed ID: 3103538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]